HK1086169A1 - Use of diphenylmethane derivatives as tyrosinase inhibitors - Google Patents

Use of diphenylmethane derivatives as tyrosinase inhibitors

Info

Publication number
HK1086169A1
HK1086169A1 HK06106227A HK06106227A HK1086169A1 HK 1086169 A1 HK1086169 A1 HK 1086169A1 HK 06106227 A HK06106227 A HK 06106227A HK 06106227 A HK06106227 A HK 06106227A HK 1086169 A1 HK1086169 A1 HK 1086169A1
Authority
HK
Hong Kong
Prior art keywords
tyrosinase inhibitors
compounds
diphenylmethane derivatives
formula
browning
Prior art date
Application number
HK06106227A
Other languages
English (en)
Inventor
Gerhard Schmaus
Martina Herrmann
Holger Joppe
Gabriele Vielhaber
Original Assignee
Symrise Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33441495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1086169(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symrise Gmbh & Co Kg filed Critical Symrise Gmbh & Co Kg
Publication of HK1086169A1 publication Critical patent/HK1086169A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/41Retaining or modifying natural colour by use of additives, e.g. optical brighteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/08Preparations for bleaching the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
HK06106227A 2003-05-30 2006-05-29 Use of diphenylmethane derivatives as tyrosinase inhibitors HK1086169A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10324566A DE10324566A1 (de) 2003-05-30 2003-05-30 Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
PCT/EP2004/050896 WO2004105736A1 (de) 2003-05-30 2004-05-24 Verwendung von diphenylmethan-derivaten als tyrosinase-inhibitoren

Publications (1)

Publication Number Publication Date
HK1086169A1 true HK1086169A1 (en) 2006-09-15

Family

ID=33441495

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106227A HK1086169A1 (en) 2003-05-30 2006-05-29 Use of diphenylmethane derivatives as tyrosinase inhibitors

Country Status (12)

Country Link
US (1) US9655824B2 (ja)
EP (1) EP1633206B1 (ja)
JP (1) JP4733018B2 (ja)
KR (1) KR101118139B1 (ja)
CN (1) CN100441174C (ja)
AT (1) ATE369755T1 (ja)
BR (1) BRPI0410888A (ja)
DE (2) DE10324566A1 (ja)
ES (1) ES2289532T3 (ja)
HK (1) HK1086169A1 (ja)
WO (1) WO2004105736A1 (ja)
ZA (1) ZA200510114B (ja)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1748767B1 (en) 2004-05-28 2011-12-28 Unigen, Inc. 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor
US20090162305A1 (en) * 2006-01-05 2009-06-25 Symrise Gmbh & Co. Kg Formulations of low oil content comprising diphenylmethane derivatives
US20090130035A1 (en) * 2006-01-05 2009-05-21 Symrise Gmbh & Co. Kg Stabilized preparations comprising phenolic compounds and benzophenones
CN100355768C (zh) * 2006-04-13 2007-12-19 暨南大学 新的酪氨酸酶抑制剂和它的用途
FR2900046A1 (fr) * 2006-04-21 2007-10-26 Oreal Compositions anti-age comprenant un derive diphenyl-methane hydroxyle
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
US20070248633A1 (en) * 2006-04-21 2007-10-25 L'oreal Compositions containing a hydroxylated diphenylmethane compound, methods of use
US7879344B2 (en) * 2006-06-29 2011-02-01 Kimberly-Clark Worldwide, Inc. Transdermal delivery of oleocanthal for relief of inflammation
US20080305059A1 (en) * 2007-06-06 2008-12-11 Chaudhuri Ratan K Skin lightening compositions and methods
EP2203151B1 (en) * 2007-10-31 2017-04-19 Amorepacific Corporation Use of melanin biosynthesis inhibitors from ginseng for skin whitening
CA2713555C (en) * 2008-02-20 2014-10-14 Elc Management Llc Topical compositions and methods for whitening skin
EP2100585A1 (fr) * 2008-03-11 2009-09-16 L'Oréal Composition cosmétique comprenant un composé d'acide ascorbique ou d'acide salicylique
PL3542780T3 (pl) * 2008-07-21 2022-05-02 Unigen, Inc. Szereg związków wybielających (rozjaśniających)
EP2381918A2 (en) 2009-01-16 2011-11-02 Neocutis SA Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
CN101474154B (zh) * 2009-01-19 2011-06-22 上海莱浦森生物科技有限公司 4-(1-苯乙基)-1,3-二羟基苯脂质体及其制备方法
FR2949330B1 (fr) 2009-08-28 2012-08-10 Oreal Composition cosmetique comprenant un derive diphenyl-methane hydroxyle
US20110081430A1 (en) * 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US8084504B2 (en) 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
FR2954140A1 (fr) 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
FR2956582B1 (fr) 2010-02-19 2012-08-24 Oreal Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16
EP2389922A1 (en) 2010-05-25 2011-11-30 Symrise AG Cyclohexyl carbamate compounds as anti-ageing actives
FR2968569B1 (fr) 2010-12-13 2013-01-04 Oreal Procede de traitement de la peau grasse non acneique.
WO2012105060A1 (en) 2011-02-04 2012-08-09 L'oreal Composite pigment and method for preparation thereof
FR2971249B1 (fr) * 2011-02-07 2013-10-18 Fabre Pierre Dermo Cosmetique Derives heterocycliques du resorcinol, leur preparation et leurs utilisations cosmetiques
ES2859700T3 (es) 2011-03-24 2021-10-04 Unigen Inc Compuestos y métodos para la preparación de diarilpropanos
WO2013010590A1 (en) 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
CA2860624A1 (en) * 2012-01-05 2013-07-11 Merz North America, Inc. Skin lightening compositions
ITBS20120092A1 (it) * 2012-06-04 2013-12-05 Paoli Ambrosi Gianfranco De Miscela per l'inibizione della biosintesi della melanina
EP2872106B2 (en) 2012-07-13 2023-08-02 L'oreal Composite pigment and method for preparing the same
US11266584B2 (en) 2012-07-13 2022-03-08 L'oreal Cosmetic composition comprising composite sunscreen particles
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
EP2789369B1 (en) 2013-04-14 2018-06-06 Symrise AG A composition for lightening skin and hair
EP2853254B1 (en) 2013-09-26 2017-11-08 Symrise AG A composition for lightening skin and/or hair
FR3012328B1 (fr) * 2013-10-30 2016-12-30 Oreal Methode de peeling cosmetique
CN103536454A (zh) * 2013-10-30 2014-01-29 东南大学 苯乙基间苯二酚羟丙基-β-环糊精包合物及其制备方法
JP6510177B2 (ja) 2014-04-01 2019-05-08 ロレアル ナノ又はマイクロエマルションの形態の組成物
JP6537788B2 (ja) * 2014-06-25 2019-07-03 ロレアル ナノエマルション若しくはマイクロエマルションの形態の又はラメラ構造を有する組成物
CN107205952A (zh) * 2014-12-09 2017-09-26 莱雅公司 包含可见珠的组合物
KR102348045B1 (ko) * 2015-02-27 2022-01-11 (주)아모레퍼시픽 미백성분의 부작용을 예측하는 방법
EP3081207B1 (en) 2015-04-16 2022-09-21 Symrise AG Use of a liposome composition
WO2017070933A1 (en) * 2015-10-30 2017-05-04 L'oreal Anhydrous composition comprising a hydroxylated diphenylmethane derivative
US20180263875A1 (en) * 2015-12-10 2018-09-20 L'oreal Composition comprising hydroxylated diphenylmethane derivatives
FR3051668B1 (fr) 2016-05-24 2020-09-04 Fl Nova Eau de source en composition a usage topique
WO2021114024A1 (en) * 2019-12-09 2021-06-17 L'oreal Composition for brightening and/or whitening keratin materials
CN112778439B (zh) * 2020-12-31 2022-03-29 广州銮滢化妆品有限公司 美白护肤品及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03130036A (ja) * 1989-10-16 1991-06-03 Seiwa Kasei Kk 食品の変色防止方法
US5202141A (en) * 1990-02-05 1993-04-13 Mcevily Arthur J Compositions and methods for inhibiting browning in foods and beverages
CA2077828A1 (en) * 1991-10-10 1993-04-11 William J. Raleigh Silicone polyether alkyl copolymer synthesis
JPH0656641A (ja) 1992-08-05 1994-03-01 Nippon Paint Co Ltd 化粧料
JPH06100433A (ja) * 1992-08-05 1994-04-12 Nippon Paint Co Ltd チロシナーゼ活性阻害剤
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
JPH07206669A (ja) * 1994-01-14 1995-08-08 Nikken Food Kk チロシナーゼ阻害活性剤
JPH07206699A (ja) 1994-01-27 1995-08-08 Teijin Ltd ペプチド、蛋白質性薬物経鼻製剤
DE69611754T2 (de) 1995-11-24 2001-05-23 Mitsui Chemicals Inc Hydrochalconderivate, sie enthaltende kosmetische zusammensetzungen, und verfahren zur herstellung von beiden
FR2744914B1 (fr) 1996-02-15 1998-03-20 Rhone Poulenc Chimie Dispersion de dioxyde de titane, poudre a base de dioxyde de titane, leur utilisation dans les formulations cosmetiques
JPH11255637A (ja) * 1998-03-13 1999-09-21 Kansai Kouso Kk チロシナーゼ活性阻害剤及び化粧料
HN2000000033A (es) * 1999-03-22 2001-02-02 Pfizer Prod Inc Composicion de resorcinol
DE10161253A1 (de) * 2001-12-13 2003-06-26 Dragoco Gerberding Co Ag Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren

Also Published As

Publication number Publication date
WO2004105736A8 (de) 2006-10-05
WO2004105736A1 (de) 2004-12-09
US20070098655A1 (en) 2007-05-03
ES2289532T3 (es) 2008-02-01
DE502004004659D1 (de) 2007-09-27
BRPI0410888A (pt) 2006-07-04
US9655824B2 (en) 2017-05-23
CN100441174C (zh) 2008-12-10
CN1798550A (zh) 2006-07-05
ZA200510114B (en) 2006-12-27
EP1633206B1 (de) 2007-08-15
JP4733018B2 (ja) 2011-07-27
DE10324566A1 (de) 2004-12-16
EP1633206A1 (de) 2006-03-15
KR101118139B1 (ko) 2012-06-20
ATE369755T1 (de) 2007-09-15
JP2006526005A (ja) 2006-11-16
KR20060014402A (ko) 2006-02-15

Similar Documents

Publication Publication Date Title
HK1086169A1 (en) Use of diphenylmethane derivatives as tyrosinase inhibitors
AP9901478A0 (en) Compounds for the treatment of ischemia.
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
DE60112974D1 (en) Carbolinderivate
EP1961418A4 (en) USE OF ISOTHIOCYANATE-BASED COMPOUNDS IN THE TREATMENT OF PROSTATIC DISEASES AND SKIN CANCER
MXPA02012000A (es) Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos.
YU40203A (sh) Orto-supstituisana bis-aril jedinjenja, koja sadrže azot, primenjena kao inhibitori kalijumovog kanala
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
HK1079522A1 (en) Thienyl compounds
DE60216233D1 (en) Carbolinderivate
GB0121490D0 (en) Ciompounds
TW200637588A (en) Whitening agent
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
MX9707022A (es) Derivados de fenilo trisustituidos.
MXPA03002911A (es) Compuestos quimicos.
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
EP1667685A4 (en) INHIBITORS OF QUINAZOLINE-BASED POTASSIUM CANAL
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
WO2004087066A3 (en) Hif-1 inhibitors
MXPA03010323A (es) Compuestos y metodos para inhibir el mal olor axilar.
EP1667976A4 (en) Isoquinolinone POTASSIUM CHANNEL INHIBITORS
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
HK1087010A1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
RS20060206A (en) Aminopyridine-derivatives as inducible no-synthase inhibitors
GB0121494D0 (en) Compounds

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240523